Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 4, 2012, Pages 645-657

  Couch, Fergus J ^a   Gaudet, Mia M ^b   Antoniou, Antonis C ^c   Ramus, Susan J ^e   Kuchenbaecker, Karoline B ^c   Soucy, Penny ^h   Beesley, Jonathan ^k   Chen, Xiaoqing ^k   Wang, Xianshu ^a   Kirchhoff, Tomas ^l   McGuffog, Lesley ^c   Barrowdale, Daniel ^c   Lee, Andrew ^c   Healey, Sue ^k   Sinilnikova, Olga M ^n,o   Andrulis, Irene L ^q,r,s,t   Ozcelik, Hilmi ^r,s   Mulligan, Anna Marie ^r,s,u   Thomassen, Mads ^v   Gerdes, Anne Marie ^w   Jensen, Uffe Birk ^x   Skytte, Anne Bine ^y   Kruse, Torben A ^v   Caligo, Maria A ^z   Von Wachenfeldt, Anna ^aa   Barbany Bustinza, Gisela ^aa   Loman, Niklas ^ab   Soller, Maria ^ab   Ehrencrona, Hans ^ac   Karlsson, Per ^ad   Nathanson, Katherine ^ae   Rebbeck, Timothy R ^ae   Domchek, Susan M ^ae   Jakubowska, Ania ^ah   Lubinski, Jan ^ah   Jaworska, Katarzyna ^ah,ai   Durda, Katarzyna ^ah   Zołwocka, Elzbieta ^ah   Huzarski, Tomasz ^ah   Byrski, Tomasz ^ah   Gronwald, Jacek ^ah   Cybulski, Cezary ^ah   Goŕski, Bohdan ^ah   Osorio, Ana ^aj   Durań, Mercedes ^al   Tejada, María Isabel ^am   Benitez, Javier ^aj   Hamann, Ute ^an   Hogervorst, Frans B L ^ap   Van Os, Theo A ^aq   Van Leeuwen, Flora E ^ap   Meijers Heijboer, Hanne E J ^ar   Wijnen, Juul ^as   Blok, Marinus J ^at   Kets, Marleen ^au   Hooning, Maartje J ^av   Oldenburg, Rogier A ^av   Ausems, Margreet G E M ^aw   Peock, Susan ^c   Frost, Debra ^c   Ellis, Steve D ^c   Platte, Radka ^c   Fineberg, Elena ^c   Evans, D Gareth ^ax   Jacobs, Chris ^ay   Eeles, Rosalind A ^bb   Adlard, Julian ^bc   Davidson, Rosemarie ^bd   Eccles, Diana M ^be   Cole, Trevor ^bf   Cook, Jackie ^bg   Paterson, Joan ^d   Brewer, Carole ^bh   Douglas, Fiona ^bi   Hodgson, Shirley V ^az   Morrison, Patrick J ^bj   Walker, Lisa ^bk   Porteous, Mary E ^bl   Kennedy, M John ^bm   Side, Lucy E ^ba   Bove, Betsy ^af   Godwin, Andrew K ^bn   Stoppa Lyonnet, Dominique ^p,bo,bp   Fassy Colcombet, Marion ^bp   Castera, Laurent ^bp   Cornelis, Franco̧is ^bq,br,bs   Mazoyer, Sylvie ^o   Leóne, Meĺanie ⁿ   Boutry Kryza, Nadia ⁿ   Bressac de Paillerets, Brigitte ^bt   Caron, Olivier ^bt   Pujol, Pascal ^bu   Coupier, Isabelle ^bu   Delnatte, Capucine ^bv   Akloul, Linda ^bv   Lynch, Henry T ^bw   Snyder, Carrie L ^bw   Buys, Saundra S ^bx   Daly, Mary B ^ag   Terry, MaryBeth ^m   Chung, Wendy K ^m   John, Esther M ^by   Miron, Alexander ^bz   Southey, Melissa C ^ca   Hopper, John L ^cb   Goldgar, David E ^bx   Singer, Christian F ^cc   Rappaport, Christine ^cc   Tea, Muy Kheng M ^cc   Fink Retter, Anneliese ^cc   Hansen, Thomas V O ^w   Nielsen, Finn C ^w   Arason, Aoalgeir ^cd,ce   Vijai, Joseph ^l   Shah, Sohela ^l   Sarrel, Kara ^l   Robson, Mark E ^l   Piedmonte, Marion ^cf   Phillips, Kelly ^ca   Basil, Jack ^cg   Rubinstein, Wendy S ^ch,ci   Boggess, John ^cj   Wakeley, Katie ^ck   Ewart Toland, Amanda ^cl   Montagna, Marco ^cm   Agata, Simona ^cm   Imyanitov, Evgeny N ^cn   Isaacs, Claudine ^co   Janavicius, Ramunas ^cp   Lazaro, Conxi ^cq   Blanco, Ignacio ^cq   Feliubadalo, Lidia ^cq   Brunet, Joan ^cq   Gayther, Simon A ^e   Pharoah, Paul P D ^c   Odunsi, Kunle O ^cf   Karlan, Beth Y ^f   Walsh, Christine S ^f   Olah, Edith ^cs   Teo, Soo Hwang ^ct,cu   Ganz, Patricia A ^g   Beattie, Mary S ^cv   Van Rensburg, Elizabeth J ^cw   Dorfling, Cecelia M ^cw   Diez, Orland ^cr   Kwong, Ava ^cx   Schmutzler, Rita K ^cy   Wappenschmidt, Barbara ^cy   Engel, Christoph ^cz   Meindl, Alfons ^da   Ditsch, Nina ^db   Arnold, Norbert ^dc   Heidemann, Simone ^dc   Niederacher, Dieter ^dd   Preisler Adams, Sabine ^de   Gadzicki, Dorothea ^df   Varon Mateeva, Raymonda ^dg   Deissler, Helmut ^dh   Gehrig, Andrea ^di   Sutter, Christian ^ao   Kast, Karin ^dj   Fiebig, Britta ^dk   Heinritz, Wolfram ^cz   Caldes, Trinidad ^ak   De La Hoya, Miguel ^ak   Muranen, Taru A ^dl   Nevanlinna, Heli ^dl   Tischkowitz, Marc D ^i,j   Spurdle, Amanda B ^k   Neuhausen, Susan L ^dm   Ding, Yuan Chun ^dm   Lindor, Noralane M ^a   Fredericksen, Zachary ^a   Pankratz, V Shane ^a   Peterlongo, Paolo ^dn   Manoukian, Siranoush ^do   Peissel, Bernard ^do   Zaffaroni, Daniela ^do   Barile, Monica ^dp   Bernard, Loris ^dp   Viel, Alessandra ^dq   Giannini, Giuseppe ^dr   Varesco, Liliana ^ds   Radice, Paolo ^dn   Greene, Mark H ^dt   Mai, Phuong L ^dt   Easton, Douglas F ^c   Chenevix Trench, Georgia ^k   Offit, Kenneth ^l   Simard, Jacques ^h   more..

^a MAYO CLINIC   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h LAVAL UNIVERSITY   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

^j MCGILL UNIVERSITY   (Canada)

^k QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^l Memorial Sloane Kettering Cancer Center   (United States)

^m Och Spine at New York Presbyterian Hospitals   (United States)

ⁿ HOSPICES CIVILS DE LYON   (France)

^o CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^p FNCLCC   (France)

^q UNIVERSITY OF TORONTO   (Canada)

^r UNIVERSITY OF TORONTO   (Canada)

^s MOUNT SINAI HOSPITAL   (Canada)

^t CANCER CARE ONTARIO   (Canada)

^u ST MICHAEL'S HOSPITAL   (Canada)

^v ODENSE UNIVERSITY HOSPITAL   (Denmark)

^w Rigshospitalet   (Denmark)

^x AARHUS UNIVERSITY HOSPITAL   (Denmark)

^y LILLEBAELT HOSPITAL   (Denmark)

^z UNIVERSITY HOSPITAL OF PISA   (Italy)

^aa KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ab LUND UNIVERSITY HOSPITAL   (Sweden)

^ac UPPSALA UNIVERSITY   (Sweden)

^ad SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^ae UNIVERSITY OF PENNSYLVANIA   (United States)

^af Clinical Molecular Genetics Laboratory   (United States)

^ag FOX CHASE CANCER CENTER   (United States)

^ah POMERANIAN MEDICAL UNIVERSITY   (Poland)

^ai MEDICAL UNIVERSITY OF WARSAW   (Poland)

^aj CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^ak HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^al UNIVERSITY OF VALLADOLID   (Spain)

^am HOSPITAL DE CRUCES   (Spain)

^an GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ao UNIVERSITY OF HEIDELBERG   (Germany)

^ap NETHERLANDS CANCER INSTITUTE   (Netherlands)

^aq ACADEMIC MEDICAL CENTER   (Netherlands)

^ar VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^as LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^at MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^au RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^av ERASMUS MEDICAL CENTER   (Netherlands)

^aw UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ax UNIVERSITY OF MANCHESTER   (United Kingdom)

^ay GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^az ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^ba GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^bb INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^bc Yorkshire Regional Genetics Service   (United Kingdom)

^bd ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^be UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^bf BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^bg SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^bh ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^bi NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^bj QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^bk CHURCHILL HOSPITAL   (United Kingdom)

^bl WESTERN GENERAL HOSPITAL   (United Kingdom)

^bm ST JAMES S HOSPITAL   (Ireland)

^bn UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^bo INSTITUT CURIE   (France)

^bp UNIVERSITÉ PARIS DESCARTES   (France)

^bq AVICENNE HOSPITAL   (France)

^br CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^bs UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^bt INSTITUT GUSTAVE ROUSSY   (France)

^bu HÔPITAL ARNAUD DE VILLENEUVE   (France)

^bv CENTRE RENÉ GAUDUCHEAU   (France)

^bw CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bx UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^by CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^bz DANA FARBER CANCER INSTITUTE   (United States)

^ca UNIVERSITY OF MELBOURNE   (Australia)

^cb PETER MACCALLUM CANCER CENTRE   (Australia)

^cc MEDICAL UNIVERSITY OF VIENNA   (Austria)

^cd LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^ce UNIVERSITY OF ICELAND   (Iceland)

^cf ROSWELL PARK CANCER INSTITUTE   (United States)

^cg GOOD SAMARITAN HOSPITAL   (United States)

^ch NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^ci UNIVERSITY OF CHICAGO   (United States)

^cj UNIVERSITY OF NORTH CAROLINA   (United States)

^ck South Shore Hospital   (United States)

^cl OHIO STATE UNIVERSITY   (United States)

^cm VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^cn N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^co GEORGETOWN UNIVERSITY   (United States)

^cp VILNIUS UNIVERSITY   (Lithuania)

^cq Hereditari Cancer Program   (Spain)

^cr VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^cs NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^ct UNIVERSITY OF MALAYA   (Malaysia)

^cu CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^cv UNIVERSITY OF CALIFORNIA   (United States)

^cw UNIVERSITY OF PRETORIA   (South Africa)

^cx HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^cy UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^cz UNIVERSITY OF LEIPZIG   (Germany)

^da TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^db UNIVERSITY OF MUNICH   (Germany)

^dc UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^dd UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^de UNIVERSITY OF MÜNSTER   (Germany)

^df HANNOVER MEDICAL SCHOOL   (Germany)

^dg Institute of Human Genetics   (Germany)

^dh UNIVERSITY HOSPITAL ULM   (Germany)

^di UNIVERSITY OF WÜRZBURG   (Germany)

^dj UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^dk UNIVERSITY OF REGENSBURG   (Germany)

^dl HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^dm CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^dn IFOM   (Italy)

^do NATIONAL CANCER INSTITUTE   (Italy)

^dp EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^dq CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^dr SAPIENZA UNIVERSITY OF ROME   (Italy)

^ds UNIVERSITY OF GENOA   (Italy)

^dt NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84859377440     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0888     Document Type: Article

References (24)

1. Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 2010;70:9742-54.
2. Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, et al. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 2011;20:3304-21.
3. Engel C, Versmold B, Wappenschmidt B, Simard J, Easton DF, Peock S, et al. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2010;19:2859-68.
4. Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011;20:3289-303.
5. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptornegative breast cancer in the general population. Nat Genet 2010;42:885-92.
6. Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010;42:880-4.
7. Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, et al. Common genetic variants and modification of penetrance of BRCA2- associated breast cancer. PLoS Genet 2010;6:e1001183.
8. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010;42:504-7.
9. Antoniou AC, Sinilnikova OM, Simard J, Leone M, Dumont M, Neuhausen SL, et al. RAD51 135G->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 2007;81:1186-200. (Pubitemid 350211449)
10. Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008;98: 1457-66. (Pubitemid 351543573)
11. Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM, Mazoyer S. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum Mol Genet 2002;11:2805-14. (Pubitemid 35331813)
12. Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, et al. Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res 2011;13:R110.
13. Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, et al. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2010; 103:105-16.
14. Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 2002;20:2310-8. (Pubitemid 34441658)
15. Shao G, Patterson-Fortin J, Messick TE, Feng D, Shanbhag N,WangY, et al. MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes Dev 2009;23:740-54.
16. Gianfrancesco F, Esposito T, Casu G, Maninchedda G, Roberto R, PirastuM. Emergence of Talanin protein associated with human uric acid nephrolithiasis in the Hominidae lineage. Gene 2004;339: 131-8. (Pubitemid 39201135)
17. Lindstrom S, Vachon CM, Li J, Varghese J, Thompson D, Warren R, et al. Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet 2011;43:185-7.
18. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007;39:596-604. (Pubitemid 46676115)
19. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
20. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-62.
21. Gianfrancesco F, Esposito T, Ombra MN, Forabosco P, Maninchedda G, Fattorini M, et al. Identification of a novel gene and acommon variant associated with uric acid nephrolithiasis in a Sardinian genetic isolate. Am J Hum Genet 2003;72:1479-91. (Pubitemid 36628387)
22. Naz G, Ali G, Naqvi SK, Azeem Z, Ahmad W. Mapping of a novel autosomal recessive hypotrichosis locus on chromosome 10q11.23- 22.3. Hum Genet 2010;127:395-401.
23. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, et al. Multiple loci with different cancer specificitieswithin the 8q24 gene desert. J Natl Cancer Inst 2008;100:962-6. (Pubitemid 351957516)
24. Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 2009;18:4442-56.